Chris Benecchi joined Sage in 2021, bringing a track record of designing commercial strategies and launching novel therapies that sustained long-term growth in highly competitive markets. In his role as Chief Business Officer, Chris leads Sage’s global commercial, medical affairs, and health economics and outcomes research (HEOR) efforts across all Sage programs, as well as corporate strategy, business development, commercial, new product planning, and alliance management. Chris most recently served as Vice President, Global Head of Commercial Excellence at Alexion, where he led integrated global launch...read more